To do so requires working together to solve the European paradox, whereby Europe has the necessary knowledge and research, but then fails to take this knowledge to market, said the Commission President.
Dubbed TREAT-NMD (Translational research in Europe - assessment and treatment of neuromuscular), the five-year network is the first of its kind in Europe, bringing together a total of 21 partner organisations from 11 countries. They include charities and companies that will work alongside doctors and researchers in the field.